TY - JOUR
T1 - Osteopontin attenuates early brain injury through regulating autophagy-apoptosis interaction after subarachnoid hemorrhage in rats
AU - Sun, Cheng Mei
AU - Enkhjargal, Budbazar
AU - Reis, Cesar
AU - Zhou, Ke Ren
AU - Xie, Zhi Yi
AU - Wu, Ling Yun
AU - Zhang, Tong Yu
AU - Zhu, Qi Quan
AU - Tang, Ji Ping
AU - Jiang, Xiao Dan
AU - Zhang, John H.
N1 - Publisher Copyright:
© 2019 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Aim: To determine the effect of osteopontin (OPN) on autophagy and autophagy-apoptosis interactions after SAH. Methods: The endovascular perforation model of SAH or sham surgery was performed in a total of 86 Sprague-Dawley male rats. The temporal expressions of endogenous OPN and autophagy-related proteins (Beclin 1, ATG5, LC3 II to I ratio) were measured in sham and SAH rats at different time points (3, 6, 12, 24, and 72 hours). Rats were randomly divided into three groups: Sham, SAH + Vehicle (PBS, phosphate-buffered saline), and SAH + rOPN (5 μg/rat recombinant OPN). Neurobehavioral tests were performed 24 hours after SAH, followed by the collection of brain samples for assessment of autophagy and apoptosis proteins. These tests assessed whether an autophagy-apoptosis relationship existed on the histological level in the brain. Results: Endogenous OPN and autophagy-related proteins all increased after SAH. rOPN administration improved neurological dysfunction, increased the expression of autophagy-related proteins (Beclin 1, ATG5, LC3 II to I ratio) and antiapoptotic protein Bcl-2, while decreasing the expression of proapoptotic proteins (cleaved Caspase-3 and Bax). rOPN also regulated autophagy-apoptosis interactions 24 hours after SAH. Conclusion: rOPN attenuates early brain injury and inhibits neuronal apoptosis by activating autophagy and regulating autophagy-apoptosis interactions.
AB - Aim: To determine the effect of osteopontin (OPN) on autophagy and autophagy-apoptosis interactions after SAH. Methods: The endovascular perforation model of SAH or sham surgery was performed in a total of 86 Sprague-Dawley male rats. The temporal expressions of endogenous OPN and autophagy-related proteins (Beclin 1, ATG5, LC3 II to I ratio) were measured in sham and SAH rats at different time points (3, 6, 12, 24, and 72 hours). Rats were randomly divided into three groups: Sham, SAH + Vehicle (PBS, phosphate-buffered saline), and SAH + rOPN (5 μg/rat recombinant OPN). Neurobehavioral tests were performed 24 hours after SAH, followed by the collection of brain samples for assessment of autophagy and apoptosis proteins. These tests assessed whether an autophagy-apoptosis relationship existed on the histological level in the brain. Results: Endogenous OPN and autophagy-related proteins all increased after SAH. rOPN administration improved neurological dysfunction, increased the expression of autophagy-related proteins (Beclin 1, ATG5, LC3 II to I ratio) and antiapoptotic protein Bcl-2, while decreasing the expression of proapoptotic proteins (cleaved Caspase-3 and Bax). rOPN also regulated autophagy-apoptosis interactions 24 hours after SAH. Conclusion: rOPN attenuates early brain injury and inhibits neuronal apoptosis by activating autophagy and regulating autophagy-apoptosis interactions.
KW - apoptosis
KW - autophagy
KW - early brain injury
KW - osteopontin
KW - subarachnoid hemorrhage
KW - Brain Injuries/metabolism
KW - Apoptosis/drug effects
KW - Autophagy/drug effects
KW - Rats
KW - Male
KW - Random Allocation
KW - Administration, Intranasal
KW - Rats, Sprague-Dawley
KW - Animals
KW - Osteopontin/administration & dosage
KW - Subarachnoid Hemorrhage/drug therapy
UR - http://www.scopus.com/inward/record.url?scp=85070876300&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070876300&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/af7936b4-e69f-3f26-b434-fb1c52349e9f/
U2 - 10.1111/cns.13199
DO - 10.1111/cns.13199
M3 - Article
C2 - 31436915
SN - 1755-5930
VL - 25
SP - 1162
EP - 1172
JO - CNS Neuroscience and Therapeutics
JF - CNS Neuroscience and Therapeutics
IS - 10
ER -